Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Daiichi Sankyo
Farmers Insurance

Generated: December 11, 2017

DrugPatentWatch Database Preview

RIFAMPIN Drug Profile

« Back to Dashboard

When do Rifampin patents expire, and what generic alternatives are available?

Rifampin is a drug marketed by Akorn, Lannett, Lupin Pharms, Sandoz, Emcure Pharms Ltd, Fresenius Kabi Usa, Hikma Pharms, Mylan Labs Ltd, Watson Pharms Teva, West-ward Pharms Int, and Hikma Intl Pharms. and is included in twelve NDAs.

The generic ingredient in RIFAMPIN is isoniazid; rifampin. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the isoniazid; rifampin profile page.
Drug patent expirations by year for RIFAMPIN

Pharmacology for RIFAMPIN

Drug ClassRifamycin Antibacterial

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AkornRIFAMPINrifampinCAPSULE;ORAL065028-001Mar 14, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozRIFAMPINrifampinCAPSULE;ORAL064150-002Jan 2, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettRIFAMPINrifampinCAPSULE;ORAL065390-002Mar 28, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma PharmsRIFAMPINrifampinINJECTABLE;INJECTION205039-001Mar 3, 2016APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozRIFAMPINrifampinCAPSULE;ORAL064150-001May 28, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hikma Intl PharmsRIFAMPIN AND ISONIAZIDisoniazid; rifampinCAPSULE;ORAL065221-001Jul 29, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson Pharms TevaRIFAMPINrifampinINJECTABLE;INJECTION206736-001Jan 19, 2016APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
AkornRIFAMPINrifampinCAPSULE;ORAL065028-002Mar 14, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LannettRIFAMPINrifampinCAPSULE;ORAL065390-001Mar 28, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Lupin PharmsRIFAMPINrifampinCAPSULE;ORAL090034-002Aug 21, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: